Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy
Mengyi Lao(Zhejiang Cancer Hospital), Xueli Bai(Zhejiang Cancer Hospital)
Cited by 14
Related Papers
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
|Cell Death and Differentiation|2022|82
Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages
|British Journal of Cancer|2019|61